-
1.
公开(公告)号:US20180169048A1
公开(公告)日:2018-06-21
申请号:US15127717
申请日:2015-03-17
Applicant: ISIS Innovation Limited
Inventor: David Smith , Fredrik Jerneren , Helga Refsum
IPC: A61K31/202 , A61K31/519 , A61K31/714 , A61K31/232 , A61K31/4415 , A61K9/00 , A61K31/205 , A61K31/14 , A61P25/28
CPC classification number: A61K31/202 , A61K9/0053 , A61K31/14 , A61K31/205 , A61K31/232 , A61K31/4415 , A61K31/519 , A61K31/714 , A61P25/28 , A61K2300/00
Abstract: The present invention provides a combined therapy comprising the use of one or more omega-3 fatty acids and one or more B vitamins and for treating cognitive impairment, such cognitive impairment disorders include, especially but not exclusively, Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The present invention also provides a treatment: for individuals suffering from cognitive impairment disorders that occur as a result of brain or cerebral atrophy, the invention includes inter alma methods of treating and/or reducing progression of brain atrophy and pharmaceutical compositions and nutritional supplements therefor.
-
2.
公开(公告)号:US10966947B2
公开(公告)日:2021-04-06
申请号:US15127717
申请日:2015-03-17
Applicant: ISIS Innovation Limited
Inventor: David Smith , Fredrik Jerneren , Helga Refsum
IPC: A61K31/202 , A61K31/519 , A61K31/714 , A61P25/28 , A61K31/4415 , A61K9/00 , A61K31/14 , A61K31/205 , A61K31/232
Abstract: The present invention provides a combined therapy comprising the use of one or more omega-3 fatty acids and one or more B vitamins and for treating cognitive impairment, such cognitive impairment disorders include, especially but not exclusively, Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). The present invention also provides a treatment for individuals suffering from cognitive impairment disorders that occur as a result of brain or cerebral atrophy, the invention includes inter alma methods of treating and/or reducing progression of brain atrophy and pharmaceutical compositions and nutritional supplements therefor.
-